Latest data from July 29, 2022
Number of Health Center respondents = 23 (85% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 4,978 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 66.48% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 1,247 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 73.63% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 30.35% | 25.02% |
| White, Hispanic/Latino Patients | 17.48% | 16.20% |
| Black/African American, Non-Hispanic/Latino Patients | 2.47% | 2.81% |
| Black/African American, Hispanic/Latino Patients | 0.14% | 0.24% |
| Asian Patients3 | 4.54% | 2.17% |
| American Indian/Alaska Native Patients3 | 2.87% | 4.17% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.86% | 0.80% |
| Patients with More Than One Race3 | 20.65% | 26.70% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 11.19% | 16.76% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.77% | 1.04% |
| Unreported/Refused to Report Race and Ethnicity | 7.67% | 4.09% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 2,098 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 61.00% |
| COVID-19 Immunization Series Completed | 2,445 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 39.57% |
| COVID-19 Immunization Series Additional | 3,892 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 56.88% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 34.75% | 53.54% | 39.65% |
| White, Hispanic/Latino Patients | 14.44% | 9.08% | 16.50% |
| Black/African American, Non-Hispanic/Latino Patients | 3.29% | 2.66% | 4.78% |
| Black/African American, Hispanic/Latino Patients | 0.10% | 0.16% | 0.10% |
| Asian Patients3 | 14.54% | 12.56% | 14.88% |
| American Indian/Alaska Native Patients3 | 1.10% | 0.41% | 2.62% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.05% | 0.78% | 0.90% |
| Patients with More Than One Race3 | 16.83% | 5.60% | 8.63% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.00% | 3.80% | 3.88% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.43% | 6.42% | 2.24% |
| Unreported/Refused to Report Race and Ethnicity | 6.48% | 4.99% | 5.83% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 8.70% |
| 1 to 24 Hours | 30.43% |
| More Than 24 Hours | 56.52% |
| N/A | 4.35% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 8.70% |
| Staffing to administer the vaccine | 34.78% |
| Vaccine confidence | 43.48% |
| Vaccine storage capacity | 4.35% |
| Vaccine supply | 8.70% |
| Other | 8.70% |
| None | 34.78% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 13.04% |
| Average Percent of Health Center Visits Conducted Virtually | 11.30% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 17.39% |
| Number of Mobile Van Sites | 1 |
| Number of Pop-up Clinics | 12 |
| Number of School-Based Vaccination Sites | 4 |
| Number of Family Vaccination Clinics | 0 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 4.35% |
| Refer patients to another organization that provides monoclonal antibody therapies | 47.83% |
| None | 47.83% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 4.35% |
| Patient awareness/education | 8.70% |
| Staffing capacity | 30.43% |
| Therapy administration/onsite logistics | 26.09% |
| Other | 8.70% |
| None | 52.17% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 14 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 9,373 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 85.71% |
| Provided to General Public Who Came to the Health Center | 42.86% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 7.14% |
| Provided at Other Community Events | 14.29% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 14.29% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 21.43% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 7.14% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 7.14% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 7.14% |
| Other | 28.57% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 7 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 16,472 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 85.71% |
| Provided to General Public Who Came to the Health Center | 85.71% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 14.29% |
| Provided at Other Community Events | 28.57% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 14.29% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 28.57% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 14.29% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 14.29% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 14.29% |
| Other | 0.00% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 12 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 61.39% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 33.97% |
| White, Hispanic/Latino Patients | 11.39% |
| Black/African American, Non-Hispanic/Latino Patients | 1.69% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 5.70% |
| American Indian/Alaska Native Patients3 | 6.54% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 31.22% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.85% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.05% |
| Unreported/Refused to Report Race and Ethnicity | 3.59% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 5.91% |
| Patients Experiencing Homelessness | 2.11% |
| Patients Who Are Residents of Public Housing | 5.49% |
| Patients with Limited English Proficiency | 16.03% |
| Children Under 18 Years of Age | 0.42% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: